EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How 31-Gene Expression Profiling Can Impact Mental Health in Patients with Cutaneous Melanoma

Kristine Kucera, Rebekah Chen, Jillian Cowan, Enid Martinez

SKIN The Journal of Cutaneous Medicine · 14.07.2026 · 10 (4) · 3250-3252

DOI: 10.25251/39q4qr14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 14.07.2026. Verfasst von Kristine Kucera und 3 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous melanoma is the fifth most common cancer in the United States, affecting approximately 2% of the population. Despite a favorable five-year survival rate of 94%, outcomes drop significantly to 34% in patients with distant metastases. Beyond the physical burden of melanoma, many survivors experience significant psychological distress, particularly fear of cancer recurrence (FCR), anxiety, and depression. To address these concerns, DecisionDx-Melanoma—a 31-gene expression profile (GEP) test—offers prognostic insight based on tumor biology and clinicopathologic staging. A 2021 Melanoma Research Foundation survey revealed that 90% of patients desired prognostic information at diagnosis and generally found the results valuable in guiding treatment and reducing uncertainty. This case study highlights the psychological and clinical utility of GEP testing in a patient with melanoma. The results allowed the patient to avoid unnecessary interventions and provided reassurance, potentially reducing anxiety and FCR. Given the high prevalence of psychological distress in melanoma patients, the integration of GEP testing into clinical care may serve as both a medical and psychosocial tool, supporting informed decision-making and improving overall patient well-being.

Zitieren

APA

Kucera, K., Chen, R., Cowan, J., & Martinez, E. (2026). How 31-Gene Expression Profiling Can Impact Mental Health in Patients with Cutaneous Melanoma. SKIN The Journal of Cutaneous Medicine, 10(4), 3250-3252. https://doi.org/10.25251/39q4qr14

Vancouver

Kucera K, Chen R, Cowan J, Martinez E. How 31-Gene Expression Profiling Can Impact Mental Health in Patients with Cutaneous Melanoma. SKIN The Journal of Cutaneous Medicine. 2026;10(4):3250-3252. doi:10.25251/39q4qr14

BibTeX
@article{Kucera2026,
  author = {Kucera, Kristine and Chen, Rebekah and Cowan, Jillian and Martinez, Enid},
  title = {How 31-Gene Expression Profiling Can Impact Mental Health in Patients with Cutaneous Melanoma},
  journal = {SKIN The Journal of Cutaneous Medicine},
  year = {2026},
  volume = {10},
  number = {4},
  pages = {3250--3252},
  doi = {10.25251/39q4qr14}
}
Kostenlos starten →